维普中文期刊产品整合服务
82篇 您的检索式:作者名="Daude C"
    题名 作者 年代 出处 被引量
1A phase I and phar- macokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors显示文摘Versehraegen C F Skubitz K Daud A 2009Canc Chemoth Pharmac2009,63,5:1
2Development and origin of the volatile fatty acids in budu显示文摘Beddows C G Ardeshir A G Daud W J 1980Joumal of the Science of Food and Agriculture1980,31,:1
3Safety and tumor responses with lambrolizumab (anti-PD-1) in melano- ma显示文摘Hamid O Robert C Daud A 2013N Engl J Med2013,369,2:1
4Safety and tumor responses with lambrolizumab ( anti-PD-1 ) in melanoma 显示文摘Hamid O Robert C Daud A 2013N Engl J Med2013,369,2:1
5Adsorption capacities of carbon dioxide, oxygen, nitrogen and methane on carbon molecular basket derived from polyethylenei- mine impregnation on microporous palm shell activated carbon显示文摘Aroua M K Daud W M A W Yin C Y 2008Separation and Purification Technology2008,62,3:1
6Effect of Bacillus subtilis on the growth and survival rate of shrimp (Litopenaeus vannamei) 显示文摘Far H Z Saad C R B Daud H M 2009African Journal of Biotechnology2009,8,14:1
7Xanthones from Garcinia mangostana (Guttiferae) 显示文摘Ee G C Daud S Taufiq-Yap Y H 2006Nat Prod Res2006,20,12:1
8Effect of Bacillus subtilis on the growth and survival rate of shrimp (Litopenaeus vannamei) 显示文摘Far H Z Saad C R B Daud H M 2009African Journal of Biotechnology2009,8,14:1
9Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma 显示文摘DAUD A I DECONTI R C ANDREWS S 2008J Clin Onco2008,26,36:1
10Safety and tumor responses with lambrolizumab (anti - PD - 1 ) in Melanoma 显示文摘Hamid 0 Robert C Daud A 2013N Engl J Med2013,369,2:1
11Safety and tumor responses with lambrolizumab ( anti-PD-1 ) in melanoma 显示文摘Hamid O Robert C Daud A 2013N Engl J Med2013,369,2:1
12Safety and tumor re- sponses with lambrolizumab ( anti - PD - 1 ) in melanoma 显示文摘HAMID O ROBERT C DAUD A 2013N Engl J Med2013,369,2:1
13Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma 显示文摘HAMID O ROBERT C DAUD A 2013N Engl J Med2013,369,2:1
14Public investment in developing countries:a blessing or a curse?显示文摘CAVALLO E DAUDE C 2011Journal of Comparative Economics2011,39,1:1
15Clinical efficacy and safety of lambrolizumab (MK-3475,Anti-PD-1 monoclonal antibody) in patients with advanced melanoma 显示文摘Ribas A Robert C Daud A 2013J Clin Oncol2013,,:1
16Safety and tumor responses with lambrelizumab ( anti-PD-1 ) in melanoma 显示文摘Hamid O Robert C Daud A 2013N Engl J Meal2013,369,2:1
17Safely and tumor re- sponses with lambrolizumab (anti-PD-1) in melanoma显示文摘Hamid O Robert C Daud A 2013N Engl J Med2013,369,2:1
18Safety and tumor re?sponses with lambrolizumab (anti-Ple-D in melanoma显示文摘Hamid 0 Robert C Daud A 2013N Engl J Med2013,369,:1
19Safety and tumor responses with lambmlizumab ( anti-PD-1 ) in melanoma 显示文摘HAMID O ROBERT C DAUD A 2013N EnglJMed2013,369,2:1
20Electronic band structure of titanium dioxide显示文摘DAUDE N GOUT C JOUANIN C 1977Phys Rev: B1977,15,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费